切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2010, Vol. 04 ›› Issue (06) : 521 -523. doi: 10.3877/cma.j.issn.1674-0793.2010.06.004

所属专题: 文献

论著

桥本病合并甲状腺癌的临床分析
陈锦1, 王朝晖1,(), 王薇1   
  1. 1. 610041 成都,四川省肿瘤医院头颈外科
  • 收稿日期:2010-01-05 出版日期:2010-12-01
  • 通信作者: 王朝晖

Clinical analysis of Hashimoto′s disease complicated with thyroid cancer

Jin CHEN1, Zhaohui WANG1,(), Wei WANG1   

  1. 1. Department of Head and Neck Surgery, Sichuan Cancer Hospital, Chengdu 610041, China
  • Received:2010-01-05 Published:2010-12-01
  • Corresponding author: Zhaohui WANG
  • About author:
    Corresponding author: WANG Zhao-hui. Email:
引用本文:

陈锦, 王朝晖, 王薇. 桥本病合并甲状腺癌的临床分析[J/OL]. 中华普通外科学文献(电子版), 2010, 04(06): 521-523.

Jin CHEN, Zhaohui WANG, Wei WANG. Clinical analysis of Hashimoto′s disease complicated with thyroid cancer[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2010, 04(06): 521-523.

目的

探讨桥本病合并甲状腺癌的临床病理特点及手术治疗经验。

方法

回顾性分析本院1996年至2008年外科手术治疗的24例桥本病与甲状腺癌并存患者的临床病理特征以及手术方式的选择。

结果

桥本病与甲状腺癌并存发生率为12.8%(24/187),其中乳头状癌16例,滤泡状癌5例,混合性癌3例;微小癌7例,占29.2%;双侧甲状腺癌6例,占25%;中央区淋巴结转移13例,占54.2%。根据患者的术前检查结合术中冰冻确定手术方式,包括甲状腺腺叶及峡叶切除、甲状腺次全切除和甲状腺全切除,所有患者均同期行中央区淋巴结清扫。

结论

桥本病与甲状腺癌并存发生率较高,桥本病并发甲状腺癌术前确诊率低,尤其应警惕合并微小癌的可能。病史、细针针吸活检、彩色超声等综合分析有利于术前诊断,手术是其最有效的治疗方法。

Objective

To investigate pathological features and surgery treatments for thyroid carcinoma associated Hashimoto’s disease.

Methods

Clinical data and pathology feature of 24 Hashimoto′s disease patients were reviewed. All of 24 patients had concurrent thyroid carcinoma and accepted surgical treatments at Sichuan Cancer Center from 1996 to 2008.

Results

Among the 24 of all 187 patients (12.8%) , 16 cases had papillary thyroid carcinoma, 5 cases had follicular thyroid carcinoma, 3 cases had mixed papillary-follicular carcinoma. Seven cases (29.2%) suffered from micro thyroid carcinoma, six cases(25%) had bilateral cancer, and 13 cases(54.2%) developed central region lymph node metastasis. Selection of thyroid lobectomy, subtotal or total parathyroidectomy were made on basis of both pre-surgery data and in-surgery frozen section histological examination. Central region lymph nodes were removed in all cases.

Conclusions

Hashimoto′s disease is preoperative diagnosed poorly, although has a high coexistence rate with thyroid carcinoma. Coexistence with micro type should be taken more caution. Comprehensive analysis with case history and the effects of fine needle aspiration and color Doppler ultrasonography have benefits on the preoperative diagnosis. Surgery procedure is the most effective.

1
黄新余,秦环龙,郑起. 桥本病并存甲状腺结节外科治疗的临床分析.中华普通外科杂志, 2005, 20(12): 780-782.
2
Intidhar Labidi S,Chaabouni AM,Kraiem J, et al. Thyroid carcinoma and Hashimoto thyroiditis. Ann Otolaryngol Chir Cerricofac, 2006, 123(4): 175.
3
Singh B,Shaha AR,Trive di H, et al. Coexistent Hashimoto’s thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery, 1999, 126(6): 1070-1076.
4
Walker RP,Paloyan E. The relationship between Hashimoto’s thyroiditis, thyroid neoplasia, and primary hyperpara-thyroidism. Otolaryngol Clin North Am, 1990, 23(8): 291-294.
5
Chetty R,O'Leary JJ,Biddolph SC, et al. Immunohistochemical detection of p53 and Bcl-2 proteins in Hashimoto's thyroiditis and primary thyroid lymphomas. J Clin Pathol, 1995, 48(3): 239-241.
6
Sclafani AP,Valdes M,Cho H. Hashimoto's thyroiditis and carcinoma of the thyroid: optimal management. Laryngoscope, 1993, 103(8): 845-849.
7
Clark OH,Greenspan FS,Dunphy JE. Hashimoto’s thyroiditis and thyroid cancer: indications for operation. Am J Surg, 1980, 140(1): 65-71.
[8]
Liu L,Bakhos R,Wojcik E. Concomitant papillary thyroid carcinoma and Hashimoto’s thyroiditis. Semin Diagn Pathol, 2001,18(2): 99.
9
Palestini N,Borasi A,Cestino L, et al. Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience.Langenbeck’s archives of surgery. Deutsche Gesellschaft fur Chirurgie, 2008, 393(5): 693-698.
10
White ML,Gauger PG,Doherty GM. Central lymph node dissection in differentiated thyroid cancer. World J Surg, 2007, 31(5): 895-904.
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志(电子版), 2024, 21(11): 1089-1091.
[2] 孙莲, 马红萍, 吴文英. 局部进展期甲状腺癌患者外科处理[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 112-114.
[3] 麻紫月, 王贞文, 张强, 赵代伟, 张翊伦. 右侧喉不返神经1例报告[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 115-116.
[4] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[5] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[6] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[7] 王秋生. 胆道良性疾病诊疗策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 779-782.
[8] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[9] 郑大雯, 王健东. 胆囊癌辅助诊断研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 769-773.
[10] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[11] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[12] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[13] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[14] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
[15] 胡云鹤, 周玉焯, 付瑞瑛, 于凡, 李爱东. CHS-DRG付费制度下GB1分组住院费用影响因素分析与管理策略探讨[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 568-574.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?